Anxiety and Epilepsy: What Neurologists and Epileptologists Should Know

Epilepsy (CW Bazil, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Epilepsy


Although there has been increasing recognition of psychiatric comorbidity in epilepsy, most research and attention in this area has focused on depression. However, comorbid anxiety in epilepsy is highly prevalent, affecting more than 40 % of patients in some reports. Many important outcomes are significantly impacted by anxiety in epilepsy, including quality of life, mortality, and seizure status. Recent evidence from epidemiologic studies suggests a bidirectional association of anxiety and epilepsy, and there is mounting evidence for possible common pathophysiology underlying anxiety and epilepsy. Despite this importance, anxiety is under-recognized and undertreated in clinical practice. A variety of anxiety symptoms are seen in epilepsy, including symptoms exclusively before, during or after seizures (peri-ictal anxiety), symptoms resembling primary anxiety disorders, and anxiety directly related to epilepsy or its treatment. Key therapeutic approaches include pharmacotherapy or cognitive behavioral therapy for most forms of interictal anxiety and better seizure control for peri-ictal anxiety.


Anxiety Epilepsy Psychiatric comorbidity Epidemiology Bidirectional relation Treatment Quality of life Prognosis Panic Phobia Obsessive compulsive disorder Suicide Antiepileptic drugs Post-traumatic stress disorder Peri-ictal anxiety Ictal anxiety Postictal anxiety Pre-ictal anxiety Selective serotonin reuptake inhibitor Serotonin-norepinephrine reuptake inhibitor Cognitive behavior therapy Interictal anxiety 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Kanner AM. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009;15:83–7. doi:10.1016/j.yebeh.2009.02.034.PubMedCrossRefGoogle Scholar
  2. 2.
    Kanner AM. Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr. 2011;11:90–1. doi:10.5698/1535-7511-11.3.90.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Beyenburg S, Mitchell AJ, Schmidt D, Elger CE, Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 2005;7:161–71. doi:10.1016/j.yebeh.2005.05.014.PubMedCrossRefGoogle Scholar
  4. 4.•
    Rai D, Kerr MP, McManus S, Jordanova V, Lewis G, Brugha TS. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia. 2012;53:1095–103. doi:10.1111/j.1528-1167.2012.03500.x. In this nationally representative, population-based study of psychiatric morbidity in England, Rai et al assessed the prevalence of various psychiatric diagnoses by structured interview and compared the association of psychiatric diagnoses with comorbid medical conditions including epilepsy, asthma, diabetes, and migraine. Key findings were significantly higher prevalence of social phobia, agoraphobia, and generalized anxiety disorder in epilepsy compared with the general population, and compared with those with asthma or diabetes.PubMedCrossRefGoogle Scholar
  5. 5.
    Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 HealthStyles Survey. Epilepsia. 2006;47:1915–21. doi:10.1111/j.1528-1167.2006.00612.x.PubMedCrossRefGoogle Scholar
  6. 6.
    Ottman R, Lipton RB, Ettinger AB, Cramer JA, Reed ML, Morrison A, et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia. 2011;52:308–15. doi:10.1111/j.1528-1167.2010.02927.x.PubMedGoogle Scholar
  7. 7.
    Stefanello S, Marin-Leon L, Fernandes PT, Li LM, Botega NJ. Psychiatric comorbidity and suicidal behavior in epilepsy: a community-based case-control study. Epilepsia. 2010;51:1120–5. doi:10.1111/j.1528-1167.2009.02386.x.PubMedCrossRefGoogle Scholar
  8. 8.
    Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110:207–20. doi:10.1111/j.1600-0404.2004.00324.x.PubMedCrossRefGoogle Scholar
  9. 9.
    Brandt C, Schoendienst M, Trentowska M, May TW, Pohlmann-Eden B, Tuschen-Caffier B, et al. Prevalence of anxiety disorders in patients with refractory focal epilepsy–a prospective clinic based survey. Epilepsy Behav. 2010;17:259–63. doi:10.1016/j.yebeh.2009.12.009.PubMedCrossRefGoogle Scholar
  10. 10.
    Swinkels WA, Kuyk J, de Graaf EH, van Dyck R, Spinhoven P. Prevalence of psychopathology in Dutch epilepsy inpatients: a comparative study. Epilepsy Behav. 2001;2:441–7. doi:10.1006/ebeh.2001.0242.PubMedCrossRefGoogle Scholar
  11. 11.
    Mensah SA, Beavis JM, Thapar AK, Kerr MP. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav. 2007;11:118–24. doi:10.1016/j.yebeh.2007.04.012.PubMedCrossRefGoogle Scholar
  12. 12.
    Devinsky O, Barr WB, Vickrey BG, Berg AT, Bazil CW, Pacia SV, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005;65:1744–9. doi:10.1212/01.wnl.0000187114.71524.c3.PubMedCrossRefGoogle Scholar
  13. 13.
    Munger Clary H, Hamberger MJ. Association of anxiety symptoms with epilepsy type and seizure localization. American Epilepsy Society Annual Meeting; San Diego, CA; 2012. www.aesnet.org2012.
  14. 14.
    Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129:256–64. doi:10.1542/peds.2010-1371.PubMedCrossRefGoogle Scholar
  15. 15.
    Jones JE, Watson R, Sheth R, Caplan R, Koehn M, Seidenberg M, et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol. 2007;49:493–7. doi:10.1111/j.1469-8749.2007.00493.x.PubMedCrossRefGoogle Scholar
  16. 16.
    Caplan R, Siddarth P, Gurbani S, Hanson R, Sankar R, Shields WD. Depression and anxiety disorders in pediatric epilepsy. Epilepsia. 2005;46:720–30. doi:10.1111/j.1528-1167.2005.43604.x.PubMedCrossRefGoogle Scholar
  17. 17.
    Adewuya AO, Ola BA. Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy. Epilepsy Behav. 2005;6:342–7. doi:10.1016/j.yebeh.2004.12.011.PubMedCrossRefGoogle Scholar
  18. 18.
    Alwash RH, Hussein MJ, Matloub FF. Symptoms of anxiety and depression among adolescents with seizures in Irbid, Northern Jordan. Seizure. 2000;9:412–6. doi:10.1053/seiz.2000.0427.PubMedCrossRefGoogle Scholar
  19. 19.
    Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia. 2004;45:544–50. doi:10.1111/j.0013-9580.2004.47003.x.PubMedCrossRefGoogle Scholar
  20. 20.
    Park SP, Song HS, Hwang YH, Lee HW, Suh CK, Kwon SH. Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy. Epilepsy Behav. 2010;18:455–9. doi:10.1016/j.yebeh.2010.05.021.PubMedCrossRefGoogle Scholar
  21. 21.
    Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ. Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia. 2010;51:1152–8. doi:10.1111/j.1528-1167.2010.02582.x.PubMedCrossRefGoogle Scholar
  22. 22.
    Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52:2168–80. doi:10.1111/j.1528-1167.2011.03213.x.PubMedCrossRefGoogle Scholar
  23. 23.
    Choi-Kwon S, Chung C, Kim H, Lee S, Yoon S, Kho H, et al. Factors affecting the quality of life in patients with epilepsy in Seoul. South Korea. Acta Neurol Scand. 2003;108:428–34.PubMedCrossRefGoogle Scholar
  24. 24.
    Kwan P, Yu E, Leung H, Leon T, Mychaskiw MA. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia. 2009;50:1059–66. doi:10.1111/j.1528-1167.2008.01938.x.PubMedCrossRefGoogle Scholar
  25. 25.
    Huang H, Che C, Liu C, Jiang F, Mao X. Factors associated with generic and disease-specific quality of life in epilepsy. Biomed Environ Sci. 2011;24:228–33. doi:10.3967/0895-3988.2011.03.00110.3967/0895-3988.2011.03.004.PubMedGoogle Scholar
  26. 26.
    Stevanovic D, Jancic J, Lakic A. The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia. 2011;52:e75–8. doi:10.1111/j.1528-1167.2011.03133.x.PubMedCrossRefGoogle Scholar
  27. 27.
    Panelli RJ, Kilpatrick C, Moore SM, Matkovic Z, D’Souza WJ, O’Brien TJ. The Liverpool Adverse Events Profile: relation to AED use and mood. Epilepsia. 2007;48:456–63. doi:10.1111/j.1528-1167.2006.00956.x.PubMedCrossRefGoogle Scholar
  28. 28.
    Gomez-Arias B, Crail-Melendez D, Lopez-Zapata R, Martinez-Juarez IE. Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs. Seizure. 2012;21:588–94. doi:10.1016/j.seizure.2012.06.003.PubMedCrossRefGoogle Scholar
  29. 29.
    Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ. Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events? Epilepsia. 2012;53:1104–8. doi:10.1111/j.1528-1167.2012.03488.x.PubMedCrossRefGoogle Scholar
  30. 30.
    Velissaris SL, Wilson SJ, Newton MR, Berkovic SF, Saling MM. Cognitive complaints after a first seizure in adulthood: influence of psychological adjustment. Epilepsia. 2009;50:1012–21. doi:10.1111/j.1528-1167.2008.01893.x.PubMedCrossRefGoogle Scholar
  31. 31.
    Au A, Leung P, Kwok A, Li P, Lui C, Chan J. Subjective memory and mood of Hong Kong Chinese adults with epilepsy. Epilepsy Behav. 2006;9:68–72. doi:10.1016/j.yebeh.2006.04.004.PubMedCrossRefGoogle Scholar
  32. 32.
    Noble AJ, Goldstein LH, Seed P, Glucksman E, Ridsdale L. Characteristics of people with epilepsy who attend emergency departments: prospective study of metropolitan hospital attendees. Epilepsia. 2012;53:1820–8. doi:10.1111/j.1528-1167.2012.03586.x.PubMedCrossRefGoogle Scholar
  33. 33.
    Hamilton KT, Anderson CT, Dahodwala N, Lawler K, Hesdorffer D, French J, et al. Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depression. Seizure. 2013. doi:10.1016/j.seizure.2013.11.012.PubMedGoogle Scholar
  34. 34.
    Stefanello S, Marin-Leon L, Fernandes PT, Li LM, Botega NJ. Depression and anxiety in a community sample with epilepsy in Brazil. Arq Neuropsiquiatr. 2011;69:342–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Gandy M, Sharpe L, Perry KN, Miller L, Thayer Z, Boserio J, et al. Rates of DSM-IV mood, anxiety disorders, and suicidality in Australian adult epilepsy outpatients: a comparison of well-controlled vs refractory epilepsy. Epilepsy Behav. 2013;26:29–35. doi:10.1016/j.yebeh.2012.10.023.PubMedCrossRefGoogle Scholar
  36. 36.
    Uebelacker LA, Weisberg R, Millman M, Yen S, Keller M. Prospective study of risk factors for suicidal behavior in individuals with anxiety disorders. Psychol Med. 2013;43:1465–74. doi:10.1017/s0033291712002504.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    VanCott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ, et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med. 2010;8:4. doi:10.1186/1741-7015-8-4.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Pugh MJ, Hesdorffer D, Wang CP, Amuan ME, Tabares JV, Finley EP, et al. Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology. 2013;81:1900–6. doi:10.1212/01.wnl.0000436614.51081.2e.PubMedCrossRefGoogle Scholar
  39. 39.
    Tang V, Kwan P, Poon WS. Neurocognitive and psychological profiles of adult patients with epilepsy in Hong Kong. Epilepsy Behav. 2013;29:337–43. doi:10.1016/j.yebeh.2013.07.027.PubMedCrossRefGoogle Scholar
  40. 40.
    Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia. 1996;37:148–61.PubMedCrossRefGoogle Scholar
  41. 41.
    Akanuma N, Hara E, Adachi N, Hara K, Koutroumanidis M. Psychiatric comorbidity in adult patients with idiopathic generalized epilepsy. Epilepsy Behav. 2008;13:248–51. doi:10.1016/j.yebeh.2008.01.006.PubMedCrossRefGoogle Scholar
  42. 42.
    de Araujo Filho GM, Pascalicchio TF, Lin K, Sousa PS, Yacubian EM. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate. Epilepsy Behav. 2006;8:606–9. doi:10.1016/j.yebeh.2006.01.016.PubMedCrossRefGoogle Scholar
  43. 43.
    Velissaris SL, Wilson SJ, Saling MM, Newton MR, Berkovic SF. The psychological impact of a newly diagnosed seizure: losing and restoring perceived control. Epilepsy Behav. 2007;10:223–33. doi:10.1016/j.yebeh.2006.12.008.PubMedCrossRefGoogle Scholar
  44. 44.
    Petrovski S, Szoeke CE, Jones NC, Salzberg MR, Sheffield LJ, Huggins RM, et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology. 2010;75:1015–21. doi:10.1212/WNL.0b013e3181f25b16.PubMedCrossRefGoogle Scholar
  45. 45.
    Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75:192–6. doi:10.1016/j.eplepsyres.2007.06.003.PubMedCrossRefGoogle Scholar
  46. 46.
    Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72:793–9. doi:10.1212/01.wnl.0000343850.85763.9c.PubMedCrossRefGoogle Scholar
  47. 47.
    Cleary RA, Thompson PJ, Fox Z, Foong J. Predictors of psychiatric and seizure outcome following temporal lobe epilepsy surgery. Epilepsia. 2012;53:1705–12. doi:10.1111/j.1528-1167.2012.03604.x.PubMedCrossRefGoogle Scholar
  48. 48.
    de Araujo Filho GM, Gomes FL, Mazetto L, Marinho MM, Tavares IM, Caboclo LO, et al. Major depressive disorder as a predictor of a worse seizure outcome one year after surgery in patients with temporal lobe epilepsy and mesial temporal sclerosis. Seizure. 2012;21:619–23. doi:10.1016/j.seizure.2012.07.002.PubMedCrossRefGoogle Scholar
  49. 49.
    Guarnieri R, Walz R, Hallak JE, Coimbra E, de Almeida E, Cescato MP, et al. Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery? Epilepsy Behav. 2009;14:529–34. doi:10.1016/j.yebeh.2009.01.002.PubMedCrossRefGoogle Scholar
  50. 50.
    Ettinger AB, Copeland LA, Zeber JE, Van Cott AC, Pugh MJ. Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals? Epilepsy Behav. 2010;17:70–4. doi:10.1016/j.yebeh.2009.10.010.PubMedCrossRefGoogle Scholar
  51. 51.
    Loney JC, Wirrell EC, Sherman EM, Hamiwka LD. Anxiety and depressive symptoms in children presenting with a first seizure. Pediatr Neurol. 2008;39:236–40. doi:10.1016/j.pediatrneurol.2008.07.005.PubMedCrossRefGoogle Scholar
  52. 52.•
    Adelow C, Andersson T, Ahlbom A, Tomson T. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology. 2012;78:396–401. doi:10.1212/WNL.0b013e318245f461. Adelöw et al carried out a nested case-control study in a population-based cohort from Stockholm, Sweden, measuring the odds of new unprovoked seizures occurring after discharge from a psychiatric hospital with diagnosis of anxiety. The age-adjusted odds ratio for unprovoked seizure was 2.6 after prior hospitalization for anxiety, demonstrating that patients with pre-existing anxiety have elevated risk of subsequent seizures/epilepsy.PubMedCrossRefGoogle Scholar
  53. 53.••
    Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72:184–91. doi:10.1002/ana.23601. This matched, longitudinal cohort study from the UK General Practice Research Database assessed incident anxiety in each of the 3 years prior to and following epilepsy onset. Incidence of anxiety was significantly elevated during each of the years assessed, compared with matched controls who did not develop epilepsy during the study period, with incidence rate ratios near 2 for each of the years assessed. These findings demonstrate that anxiety risk is elevated both prior to and after onset of epilepsy.PubMedCrossRefGoogle Scholar
  54. 54.••
    Hesdorffer DC, Caplan R, Berg AT. Familial clustering of epilepsy and behavioral disorders: evidence for a shared genetic basis. Epilepsia. 2012;53:301–7. doi:10.1111/j.1528-1167.2011.03351.x. Hesdorffer et al tested the hypothesis that epilepsy and behavior disorders cluster in families by assessing first-degree family history of unprovoked seizures and presence of behavioral disorders among participants in the Connecticut Study of Epilepsy, a prospective study of new onset childhood epilepsy. Parent-report of anxiety disorder on a DSM-oriented scale at 9 year follow-up was significantly associated with history of unprovoked seizures in the family. These findings suggest a possible underlying genetic predisposition for epilepsy and anxiety.PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Schenkel LC, Bragatti JA, Becker JA, Torres CM, Martin KC, de Souza AC, et al. Serotonin gene polymorphisms and psychiatry comorbidities in temporal lobe epilepsy. Epilepsy Res. 2012;99:260–6. doi:10.1016/j.eplepsyres.2011.12.005.PubMedCrossRefGoogle Scholar
  56. 56.
    Kanner AM. Psychiatric comorbidities and epilepsy: is it the old story of the chicken and the egg? Ann Neurol. 2012;72:153–5. doi:10.1002/ana.23679.PubMedCrossRefGoogle Scholar
  57. 57.
    Harden CL, Goldstein MA, Ettinger A. Anxiety Disorders in Epilepsy. In: Ettinger A, Kanner A, editors. Psychiatric Issues in Epilepsy. Philadelphia: Lippincott, Williams &Wilkins; 2007.Google Scholar
  58. 58.
    Savic I, Lindstrom P, Gulyas B, Halldin C, Andree B, Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. 2004;62:1343–51.PubMedCrossRefGoogle Scholar
  59. 59.
    Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24:589–91. doi:10.1523/JNEUROSCI.4921-03.2004.PubMedCrossRefGoogle Scholar
  60. 60.
    Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci. 1992;50:319–26.PubMedCrossRefGoogle Scholar
  61. 61.
    Jobe PC, Mishra PK, Browning RA, Wang C, Adams-Curtis LE, Ko KH, et al. Noradrenergic abnormalities in the genetically epilepsy-prone rat. Brain Res Bull. 1994;35:493–504.PubMedCrossRefGoogle Scholar
  62. 62.
    Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry. 1998;55:715–20.PubMedCrossRefGoogle Scholar
  63. 63.
    Cendes F, Andermann F, Gloor P, Gambardella A, Lopes-Cendes I, Watson C, et al. Relationship between atrophy of the amygdala and ictal fear in temporal lobe epilepsy. Brain. 1994;117(Pt 4):739–46.PubMedCrossRefGoogle Scholar
  64. 64.
    Van Paesschen W, King MD, Duncan JS, Connelly A. The amygdala and temporal lobe simple partial seizures: a prospective and quantitative MRI study. Epilepsia. 2001;42:857–62.PubMedCrossRefGoogle Scholar
  65. 65.
    Blackmon K, Barr WB, Carlson C, Devinsky O, Dubois J, Pogash D, et al. Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety. Psychiatry Res. 2011;194:296–303. doi:10.1016/j.pscychresns.2011.05.007.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Kimiskidis VK, Valeta T. Epilepsy and anxiety: epidemiology, classification, etiology, and treatment. Epileptic Disord. 2012;14:248–56. doi:10.1684/epd.2012.0524.PubMedGoogle Scholar
  67. 67.
    Haut SR, Hall CB, Masur J, Lipton RB. Seizure occurrence: precipitants and prediction. Neurology. 2007;69:1905–10. doi:10.1212/01.wnl.0000278112.48285.84.PubMedCrossRefGoogle Scholar
  68. 68.
    Blanchet P, Frommer GP. Mood change preceding epileptic seizures. J Nerv Ment Dis. 1986;174:471–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Goldstein MA, Harden CL. Epilepsy and anxiety. Epilepsy Behav. 2000;1:228–34. doi:10.1006/ebeh.2000.0080.PubMedCrossRefGoogle Scholar
  70. 70.
    Sazgar M, Carlen PL, Wennberg R. Panic attack semiology in right temporal lobe epilepsy. Epileptic Disord. 2003;5:93–100.PubMedGoogle Scholar
  71. 71.
    Mintzer S, Lopez F. Comorbidity of ictal fear and panic disorder. Epilepsy Behav. 2002;3:330–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Kanner AM, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 2004;62:708–13.PubMedCrossRefGoogle Scholar
  73. 73.
    Dunn DW, Austin JK, Perkins SM. Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures. Dev Med Child Neurol. 2009;51:364–72. doi:10.1111/j.1469-8749.2008.03172.x.PubMedCentralPubMedCrossRefGoogle Scholar
  74. 74.
    Kaplan PW. Epilepsy and obsessive-compulsive disorder. Dialogues Clin Neurosci. 2010;12:241–8.PubMedCentralPubMedGoogle Scholar
  75. 75.
    Isaacs KL, Philbeck JW, Barr WB, Devinsky O, Alper K. Obsessive-compulsive symptoms in patients with temporal lobe epilepsy. Epilepsy Behav. 2004;5:569–74. doi:10.1016/j.yebeh.2004.04.009.PubMedCrossRefGoogle Scholar
  76. 76.
    Chung MC, Allen RD. Alexithymia and posttraumatic stress disorder following epileptic seizure. Psychiatr Q. 2013;84:271–85. doi:10.1007/s11126-012-9243-1.PubMedCrossRefGoogle Scholar
  77. 77.
    Chung MC, Allen RD, Dennis I. The impact of self-efficacy, alexithymia and multiple traumas on posttraumatic stress disorder and psychiatric co-morbidity following epileptic seizures: a moderated mediation analysis. Psychiatry Res. 2013;210:1033–41. doi:10.1016/j.psychres.2013.07.041.PubMedCrossRefGoogle Scholar
  78. 78.
    Newsom-Davis I, Goldstein LH, Fitzpatrick D. Fear of seizures: an investigation and treatment. Seizure. 1998;7:101–6.PubMedCrossRefGoogle Scholar
  79. 79.
    de Souza EA, Salgado PC. A psychosocial view of anxiety and depression in epilepsy. Epilepsy Behav. 2006;8:232–8. doi:10.1016/j.yebeh.2005.10.011.PubMedCrossRefGoogle Scholar
  80. 80.
    Gandy M, Sharpe L, Perry KN. Psychosocial predictors of depression and anxiety in patients with epilepsy: a systematic review. J Affect Disord. 2012;140:222–32. doi:10.1016/j.jad.2011.11.039.PubMedCrossRefGoogle Scholar
  81. 81.
    Frey LC, Strom LA, Shrestha A, Spitz MC. End-of-dose emergent psychopathology in ambulatory patients with epilepsy on stable-dose lamotrigine monotherapy: a case series of 6 patients. Epilepsy Behav. 2009;15:521–3. doi:10.1016/j.yebeh.2009.05.008.PubMedCrossRefGoogle Scholar
  82. 82.
    Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317–25.PubMedCrossRefGoogle Scholar
  83. 83.
    Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia. 2013;54 Suppl 1:3–12. doi:10.1111/epi.12100.PubMedCrossRefGoogle Scholar
  84. 84.
    Andrewes D, Camp K, Kilpatrick C, Cook M. The assessment and treatment of concerns and anxiety in patients undergoing presurgical monitoring for epilepsy. Epilepsia. 1999;40:1535–42.PubMedCrossRefGoogle Scholar
  85. 85.
    Macrodimitris S, Wershler J, Hatfield M, Hamilton K, Backs-Dermott B, Mothersill K, et al. Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety. Epilepsy Behav. 2011;20:83–8. doi:10.1016/j.yebeh.2010.10.028.PubMedCrossRefGoogle Scholar
  86. 86.
    Gillham RA. Refractory epilepsy: an evaluation of psychological methods in outpatient management. Epilepsia. 1990;31:427–32.PubMedCrossRefGoogle Scholar
  87. 87.
    Au A, Chan F, Li K, Leung P, Li P, Chan J. Cognitive-behavioral group treatment program for adults with epilepsy in Hong Kong. Epilepsy Behav. 2003;4:441–6.PubMedCrossRefGoogle Scholar
  88. 88.
    Blocher JB, Fujikawa M, Sung C, Jackson DC, Jones JE. Computer-assisted cognitive behavioral therapy for children with epilepsy and anxiety: a pilot study. Epilepsy Behav. 2013;27:70–6. doi:10.1016/j.yebeh.2012.12.014.PubMedCrossRefGoogle Scholar
  89. 89.
    Tsounis S, Kimiskidis VK, Kazis D, Gkiatas K, Garganis K, Karageorgiou K, et al. An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece. Seizure. 2011;20:701–5. doi:10.1016/j.seizure.2011.06.022.PubMedCrossRefGoogle Scholar
  90. 90.
    Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, et al. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumor-related epilepsy: a pilot study. Epileptic Disord. 2012;14:388–97. doi:10.1684/epd.2012.0542.PubMedGoogle Scholar
  91. 91.
    Brandt C, Schoendienst M, Trentowska M, Schrecke M, Fueratsch N, Witte-Boelt K, et al. Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders—results of an open-label, parallel group, investigator-initiated, proof-of-concept study. Epilepsy Behav. 2013;29:298–304. doi:10.1016/j.yebeh.2013.08.004.PubMedCrossRefGoogle Scholar
  92. 92.
    Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC. Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol. 2008;23:18–28. doi:10.1097/YIC.0b013e3282f0f0d7.PubMedCrossRefGoogle Scholar
  93. 93.
    Mula M. Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia. 2013;54 Suppl 1:13–8. doi:10.1111/epi.12101.PubMedCrossRefGoogle Scholar
  94. 94.
    Kanner AM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Sem Neurol. 2008;28:379–88. doi:10.1055/s-2008-1079342.CrossRefGoogle Scholar
  95. 95.
    Spina E, Trifiro G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs. 2012;26:39–67. doi:10.2165/11594710-000000000-00000.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Wake Forest University School of MedicineWinston-SalemUSA

Personalised recommendations